Cyclacel Pharmaceuticals Stock (NASDAQ: CYCC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.29K / 75.76K |
Day Range | - - - |
52 Wk Range | 0.95 - 11.34 |
Market Cap | $2.12M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 2.95% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) through any online brokerage.
Other companies in Cyclacel Pharmaceuticals’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Scinai Immunotherapeutics (NASDAQ:SCNI).
Cyclacel Pharmaceuticals has a consensus price target of $9.50.
The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCC) is $1.072 last updated September 24, 2024 at 7:58 AM EDT.
There are no upcoming dividends for Cyclacel Pharmaceuticals.
Cyclacel Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Cyclacel Pharmaceuticals.
Cyclacel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.